MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$0.48
-0.03 (-6.02%)
As of Jul 4, 10:40 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +3,937.8% upside
Low Target $16.83
Average Target $19.24
High Target $29.48
Current Price $0.48
Current
$0.48
Target
$19.24
$16.83 $19.24 avg $29.48
Scenario Analysis
Bear Case
$16.83
3,432.0%
Low target
Base Case
$19.24
+3,937.8%
Avg target
Bull Case
$29.48
+6,086.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.33
-91.1% from high
52-Week Low
$0.40
+19.1% from low
Target vs 52W High
$19.24
+261.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 -1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -49.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +176.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -88.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -67.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.8%